Recent ETON News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:25:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:21:24 PM
- Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 08:01:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:16:27 PM
- Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • GlobeNewswire Inc. • 07/30/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 08:16:01 PM
- Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) • GlobeNewswire Inc. • 07/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:18:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:25:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:17:24 PM
- Eton Pharmaceuticals Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:01:00 PM
- Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/29/2024 08:30:00 PM
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria • GlobeNewswire Inc. • 03/22/2024 06:00:00 AM
- Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/14/2024 08:01:00 PM
- Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 11:55:25 AM
- Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation • GlobeNewswire Inc. • 02/21/2024 11:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:21:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:19:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:17:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:55:44 AM
- Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules • GlobeNewswire Inc. • 02/02/2024 11:50:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:25:42 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM